Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

2.89
-0.1303-4.27%
Volume:143.74K
Turnover:417.45K
Market Cap:16.74M
PE:1.34
High:3.00
Open:3.00
Low:2.84
Close:3.05
Loading ...
Jun 19, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 28, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
May 17, 2019

Major Issues Report

[Amend] Current report, item 5.02
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 13, 2019

Major Issues Report

[Amend] Current report, item 9.01
Apr 26, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 15, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Apr 12, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Apr 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 11, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Apr 03, 2019

Major Issues Report

[Amend] Current report, item 9.01
Apr 02, 2019

Major Issues Report

Current report, item 5.02
Apr 01, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Mar 19, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 13, 2019

Major Issues Report

Current report, items 2.01, 2.03, 3.03, 5.01, 5.02, 5.03, 5.07, 8.01, and 9.01
Mar 11, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]